SUVN-911(compound 9h)
97%
- Product Code: 109701
CAS:
2414674-71-6
| Molecular Weight: | 261.147 g./mol | Molecular Formula: | C₁₁H₁₄Cl₂N₂O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
SUVN-911 is primarily explored for its potential therapeutic applications in the treatment of neurological and psychiatric disorders. It acts as a selective antagonist for the 5-HT6 receptor, which is implicated in cognitive processes and mood regulation. Research indicates its potential use in addressing conditions such as Alzheimer’s disease, where it may help improve memory and cognitive function by modulating serotonin signaling in the brain. Additionally, it is being investigated for its efficacy in managing symptoms of depression and anxiety, offering a novel approach to treatment by targeting specific serotonin receptors. Preclinical studies suggest that SUVN-911 could also play a role in reducing neuroinflammation and promoting neuroprotection, making it a promising candidate for further development in neurodegenerative and mental health therapies.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $1,007.24 |
+
-
|
| 0.010 | 10-20 days | $1,648.44 |
+
-
|
SUVN-911(compound 9h)
SUVN-911 is primarily explored for its potential therapeutic applications in the treatment of neurological and psychiatric disorders. It acts as a selective antagonist for the 5-HT6 receptor, which is implicated in cognitive processes and mood regulation. Research indicates its potential use in addressing conditions such as Alzheimer’s disease, where it may help improve memory and cognitive function by modulating serotonin signaling in the brain. Additionally, it is being investigated for its efficacy in managing symptoms of depression and anxiety, offering a novel approach to treatment by targeting specific serotonin receptors. Preclinical studies suggest that SUVN-911 could also play a role in reducing neuroinflammation and promoting neuroprotection, making it a promising candidate for further development in neurodegenerative and mental health therapies.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :